Funded Tech Companies
Elusys Therapeutics
Wondering who invested in Elusys Therapeutics? INVESCO Private Capital, EW Healthcare Partners and MedImmune Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Elusys Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4 Century Dr. 260
Parsippany, NJ 07054
USA
Parsippany, NJ 07054
USA
Phone
Website
Email Address
Company Background Information
Overview
Elusys Therapeutics is a private company focused on the development of antibody therapeutics for the treatment of infectious disease. For over 10 years, Elusys has been engaged in development of new therapies for the treatment of anthrax exposure following a natural or intentional release of anthrax spores.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2007
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elizabeth Posillico
VP - Bus. Development
Jeremy Middleton
VP - Finance
Vera Wong
VP - Manufacturing
James Porter
VP - Regulatory Affairs
Robin Conrad
Company Investors
- INVESCO Private Capital (John Evans)
- EW Healthcare Partners (Martin Sutter)
- MedImmune Ventures
- Crescendo Ventures
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs